ArticleACS nano2026
Decoupling Optical Functions via Ratio-Tunable Conjugated Copolymers with Hydrogen-Bond-Enforced Rigidity for Quenching-Resistant NIR-II Phototheranostics.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Organic near-infrared II (NIR-II) phototheranostic agents hold great promise for tumor imaging and phototherapy. However, their development is fundamentally challenged by the coupled and competing optical pathways in conventional designs: rigid planar fluorophores that excel in the molecular state often suffer from severe aggregation-caused quenching (ACQ) in nanoparticles, leading to drastic losses in both fluorescence and reactive oxygen species (ROS) generation. To decouple these optical functions, we report a modular copolymer-based anti-quenching strategy by integrating a flexible segment with a hydrogen-bond-enforced rigid segment. The key to decoupling lies in the tunable segment ratio, which allows composition-dependent modulation with reduced trade-offs of NIR-II fluorescence, ROS production, and photothermal conversion. As the rigid-segment fraction increases in the copolymer series (F8R2, F5R5, and F2R8), NIR-II fluorescence and ROS generation are markedly enhanced, while the photothermal conversion efficiency is only slightly compromised. Remarkably, the F2R8 nanoparticles (80% rigid segment) retain >60% of their NIR-II fluorescence and high ROS productivity in the aggregated state, starkly contrasting the >90% quenching observed in conventional ACQ-type small molecules. This effective partial decoupling of optical functions and suppression of ACQ enable high-contrast NIR-II fluorescence imaging-guided combined phototherapy in vivo. Our work provides a general design paradigm based on copolymer modularity for developing high-performance quenching-resistant organic phototheranostics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.